The holiday season often involves long flights to reunite with loved ones or explore new destinations. While air travel is ...

Researchers gathered real-world data on biologic therapy to determine the feasibility of targeting clinical remission when ...

Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic ...

LONDON — AstraZeneca's AZN.L Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

Mepolizumab effectively reduces exacerbations in severe asthma and concurrent COPD, but further research on factors like ...

Inhaled insulin is not recommended for the treatment of diabetic ... Afrezza is contraindicated in patients with chronic lung ...

Company plans to meet with FDA regarding potential sNDA submission in 1H 2025Call planned today at 8:30 a.m. (ET) to discuss company’s diabetes ...

This announcement comes after Baldwin launched an investigation into the extremely high prices pharmaceutical companies ...

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

Factors that can increase the risk of COPD include exposure to tobacco smoke, including secondhand smoke; asthma; occupational exposure to ... Treatment for COPD can include medications, such as ...

.In December 2024:- AstraZeneca- A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect ...